GENFIT
Carol Addy has over 30 years working in the healthcare and wellness space, including leading clinical development teams in the pharmaceutical industry (Merck) and supporting life-cycle management of approved therapies for obesity.
Prior to joining GENFIT, she was Chief Medical Officer at HMR Weight Management Services Corp., a wholly owned subsidiary of Merck. Carol Addy holds an M.D. degree from the University of Massachusetts Medical School and a Masters of Medical Science degree from Harvard Medical School.
Carol is GENFIT’s CMO, effective on September 2, 2019.
This person is not in any offices
GENFIT
4 followers
GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved treatments.